Schiff gets 2nd takeover offer

Share this article:

Consumer goods firm Reckitt Benckiser commenced a tender offer for vitamin and supplement company Schiff valued at $200 million more than an acquisition deal Schiff already signed with Bayer HealthCare.

Reckitt's bid for Schiff came in at $42.00 per share in cash, valuing Schiff at $1.4 billion—a 23.5% premium over Bayer's bid.

On October 30, Schiff signed a deal to be acquired by Bayer Healthcare in a transaction valued at $1.2 billion.

Schiff markets OTC brands Omega 3 supplement MegaRed and Airborne immune system health supplement, as well as nutrition bars and vitamins.
Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Features

Email Newsletters

MM&M Future Leaders


Register now

Early bird $1,950 before 31 October 2014

*Group discounts available on request 

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Features

Read the complete October 2014 Digital Edition

Read the complete October 2014 Digital Edition

Click the above link to access the complete Digital Edition of the October 2014 issue of MM&M, with all text, charts and pictures.

Predicting your pink slip

Predicting your pink slip

Any time a firm needs to save money, high-salaried executives are targets

Private View: New ways to engage with customers

Private View: New ways to engage with customers

These healthcare social media campaigns successfully use emotion, altruism and the human desire to "brand" oneself to get customers engaged.